Rajula Gaur

Lead Scientist with comprehensive expertise in clinical and translational settings, specializing in the identification and implementation of pharmacodynamic biomarkers. Proven track record in validating biomarkers for clinical studies, supporting target credentialing in multiple disease indications including rheumatology, inflammatory bowel disease, multiple sclerosis, chronic obstructive pulmonary disease, and exploring mechanisms of action of lead compounds. Expertise includes: • Leading biomarker programs in early clinical studies for drug targets in Immuno-Inflammatory diseases • Establishing pharmacodynamic (PD) biomarker and target engagement assays for early clinical trials in healthy volunteers and patients • Experience leading without authority and in muti-functional matrixed and global environments • Managing interactions with internal teams and external vendors (CROs) for biomarker assay transfer and validation • Developing strategic plans for patient stratification using biomarker assays for clinical development projects • Collaborating across multiple research areas for Immuno-Inflammation including inflammatory bowel disease, rheumatology diseases, multiple sclerosis, COPD and IPF. • Possessing versatile management skills with the ability to communicate effectively with internal and external partners